Synergistic antibacterial effect and improved pharmacokinetics of florfenicol in combination with sulfamonomethoxine sodium
Journal of Antimicrobial Chemotherapy · 03.11.2026 · 81 (12)
DOI: 10.1093/jac/dkag386 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 13.11.2026. Verfasst von Xiaoyang Ai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611130, China. Hauptthemen laut MEDLINE: Thiamphenicol, Anti-Bacterial Agents, Drug Synergism, Sulfamonomethoxine. Die Arbeit nennt 64 Literaturangaben. Gefördert von: Sichuan Agricultural University.
Abstract (Originalsprache)
Objective
Florfenicol (FFC) and sulfamonomethoxine sodium (SMM-Na) are both broad-spectrum antibiotics for animals. FFC inhibits bacterial protein synthesis, whereas SMM-Na inhibits the bacterial folate pathway, suggesting a potential for synergy. However, the pharmacodynamic and pharmacokinetic interactions of their combination remain uncharacterized. This study evaluated the in vitro and in vivo interactions between FFC and SMM-Na.
Methods
The in vitro interaction was assessed against several bacterial strains using the checkerboard method to determine the fractional inhibitory concentration index (FICI). The physicochemical stability of the combination was tested. An in situ recirculating intestinal perfusion model in rats was used to assess absorption parameters. Pharmacokinetic studies in rats compared the combination therapy to monotherapies. The therapeutic efficacy was evaluated in a mouse model of Staphylococcus aureus pulmonary infection, with the combination administered at half the individual monotherapy doses.
Results
The FFC/SMM-Na combination demonstrated synergistic effects (FICI = 0.375) in vitro and remained stable for 7 h. Intestinal perfusion showed the combination significantly increased the absorption rate constants (Ka) and effective permeability coefficients (Peff) for both drugs. Pharmacokinetic analysis revealed improved relative bioavailability for both FFC (113.98%) and SMM-Na (113.29%), with distinct pharmacokinetic profiles: FFC showed higher Cmax and shorter Tmax, while SMM-Na exhibited lower Cmax and longer Tmax. In the infection model, the half-dose combination achieved a significant reduction in bacterial load and ameliorated lung pathology.
Conclusion
The FFC/SMM-Na combination exhibits synergistic antibacterial activity in vitro, enhances mutual intestinal absorption, improves the pharmacokinetic profiles of both drugs, and achieves comparable in vivo efficacy at reduced doses through a dose-sparing effect. These findings provide a pharmacological basis for the clinical exploration of this combination therapy against bacterial infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611130, China.
Förderung
- Sichuan Agricultural University
Zitieren
APA
Ai, X., Lan, J., Li, N., Chen, Y., Chen, L., Zhang, W., Shu, G., Lin, J., Li, H., Xu, F., & Fu, H. (2026). Synergistic antibacterial effect and improved pharmacokinetics of florfenicol in combination with sulfamonomethoxine sodium. Journal of Antimicrobial Chemotherapy, 81(12). https://doi.org/10.1093/jac/dkag386
Vancouver
Ai X, Lan J, Li N, Chen Y, Chen L, Zhang W, et al. Synergistic antibacterial effect and improved pharmacokinetics of florfenicol in combination with sulfamonomethoxine sodium. Journal of Antimicrobial Chemotherapy. 2026;81(12). doi:10.1093/jac/dkag386
BibTeX
@article{Ai2026,
author = {Ai, Xiaoyang and Lan, Jinping and Li, Nanxin and Chen, Yixing and Chen, Lian and Zhang, Wei and Shu, Gang and Lin, Juchun and Li, Haohuan and Xu, Funeng and Fu, Hualin},
title = {Synergistic antibacterial effect and improved pharmacokinetics of florfenicol in combination with sulfamonomethoxine sodium},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2026},
volume = {81},
number = {12},
doi = {10.1093/jac/dkag386}
}
EUVIMED